Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate–protein kinase a pathway
Haofeng Ji, Yu Zhang, Yuanxing Liu, Xiu‐Da Shen, Feng Gao, Terry T. Nguyen, Ronald W. Busuttil, James A. Waschek, Jerzy W. Kupiec‐Weglinski – 7 June 2013 – Hepatic ischemia/reperfusion injury (IRI), an exogenous, antigen‐independent, local inflammation response, occurs in multiple clinical settings, including liver transplantation, hepatic resection, trauma, and shock. The nervous system maintains extensive crosstalk with the immune system through neuropeptide and peptide hormone networks.